Biography



<< Back

Mårten Steen, MD, PhD
Mårten has served as a member of our board of directors since December 2014. Since April 2010, he has served as a partner of HealthCap VI LP, a venture capital firm investing in life science companies. Prior to HealthCap, he served as director at Merck Serono SA, a biopharmaceutical company. Mårten currently serves on the board of directors of Wilson Therapeutics AB, Altimmune Inc., and BioClin Therapeutics Inc. He previously served on the board of directors of Ultragenyx Inc. and FerroKin Biosciences.

Mårten holds an MD and a PhD in clinical chemistry and a BSc in business administration, all from Lund University.








© 2019 Strongbridge Biopharma plc
STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Dublin Limited and Strongbridge U.S. Inc.
KEVEYIS® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc.
MLR-0010 V15 01/2019

  • Ireland Address:
    Suite 206, Fitzwilliam Hall
    Fitzwilliam Place, Dublin 2, D02 T292
    Ireland
  • U.S. Address:
    900 Northbrook Drive, Suite 200
    Trevose, PA 19053
    United States

Phone: +1 610-254-9200
[email protected]

Privacy Statement
Compliance Program